Nurix Therapeutics Insider Sells Shares Worth $90,000
Christine Ring, Chief Legal Officer of Nurix Therapeutics (NRIX), sold 5,394 shares for approximately $90,000 on May 1, 2026. The transaction reduced her direct equity holdings by 16.94%, leaving her with 26,453 shares. The sale is part of a pattern of recent larger transactions, but this particular one is smaller in size.
Tickers: $NRIX
Topics: insider trading Nurix Therapeutics SEC Form 4 stock sales